127 related articles for article (PubMed ID: 12174874)
21. Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas.
Xerri L; Carbuccia N; Parc P; Hassoun J; Birg F
Histopathology; 1995 Sep; 27(3):235-41. PubMed ID: 8522287
[TBL] [Abstract][Full Text] [Related]
22. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
[TBL] [Abstract][Full Text] [Related]
23. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions.
Caudroy S; Polette M; Tournier JM; Burlet H; Toole B; Zucker S; Birembaut P
J Histochem Cytochem; 1999 Dec; 47(12):1575-80. PubMed ID: 10567441
[TBL] [Abstract][Full Text] [Related]
24. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
26. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
[TBL] [Abstract][Full Text] [Related]
28. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
Tsurumi H; Takahashi T; Moriwaki H; Muto Y
Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
[TBL] [Abstract][Full Text] [Related]
29. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.
Gabison EE; Mourah S; Steinfels E; Yan L; Hoang-Xuan T; Watsky MA; De Wever B; Calvo F; Mauviel A; Menashi S
Am J Pathol; 2005 Jan; 166(1):209-19. PubMed ID: 15632013
[TBL] [Abstract][Full Text] [Related]
31. Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma.
Gualco G; Weiss LM; Bacchi CE
Hum Pathol; 2008 Oct; 39(10):1505-10. PubMed ID: 18620733
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of extracellular matrix metalloproteinase inducer in human endometrium during the menstrual cycle in vivo and in vitro.
Noguchi Y; Sato T; Hirata M; Hara T; Ohama K; Ito A
J Clin Endocrinol Metab; 2003 Dec; 88(12):6063-72. PubMed ID: 14671212
[TBL] [Abstract][Full Text] [Related]
33. [Hodgkin's disease and anaplastic large cell lymphoma in 1998].
Delsol G; Lamant L; al Saati T; Auvigne I; Brousset P
Ann Pathol; 1998 Oct; 18(4):331-42. PubMed ID: 9827224
[No Abstract] [Full Text] [Related]
34. Application of Newly Developed Tissue-arrays to Study EMMPRIN (CD147) Expression in Malignant Non-Hodgkin Lymphoma.
Thorns C; Noack F; Feller AC; Merz H; Stöcker W; Mueller-Kunert E; Bernd HW
Cancer Genomics Proteomics; 2004; 1(1):45-52. PubMed ID: 31394617
[TBL] [Abstract][Full Text] [Related]
35. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
[TBL] [Abstract][Full Text] [Related]
36. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions.
Sidhu SS; Mengistab AT; Tauscher AN; LaVail J; Basbaum C
Oncogene; 2004 Jan; 23(4):956-63. PubMed ID: 14749763
[TBL] [Abstract][Full Text] [Related]
37. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Tang Y; Kesavan P; Nakada MT; Yan L
Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic large cell lymphomas: a study of 75 pediatric patients.
d'Amore ES; Menin A; Bonoldi E; Bevilacqua P; Cazzavillan S; Donofrio V; Gambini C; Forni M; Gentile A; Magro G; Boldrini R; Pillon M; Rosolen A; Alaggio R
Pediatr Dev Pathol; 2007; 10(3):181-91. PubMed ID: 17535098
[TBL] [Abstract][Full Text] [Related]
39. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Bozkurt C; Ertem U; Oksal A; Sahin G; Yüksek N; Birgen D
Pediatr Hematol Oncol; 2008 Sep; 25(7):621-9. PubMed ID: 18850474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
